Recruiting

Observational Study

Sponsor:

Montreal Heart Institute

Code:

NCT03412448

Conditions

Chronic Pain

Cardiac Surgery

Opioid Use

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

observation

Study Details

Brief summary:

The authors propose to evaluate the prevalence of chronic post-operative pain (CPOP) and continued opioid use in the population that has undergone cardiac surgery at the Montreal Heart Institute. In addition, the authors wish to evaluate the presence of known risk factors for CPOP in this population.

Conditions

Chronic Pain

Cardiac Surgery

Opioid Use

Study ID

NCT03412448

Start date

Jun 1, 2017

Status verified date

Jan, 2018

Completion date

Aug 1, 2018

Anticipated

Primary completion date

Jun 15, 2018

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

All patients who have surgery at the Montreal Heart Institute between October 1 2017 and October 1 2018 will be eligible for selection.

Exclusion Criteria:

Patients who have declined to be contacted after surgery as noted on the MHI form "Consent for futur projects".

All patients who accepted to be contacted but decline to participate when contacted after their surgery.

Patients who cannot be reached by phone. Patients who cannot speak French

Study Design

Enrollment

320 participants

Anticipated

Interventions and Outcome Measures

Interventions

observation

Observation,

Primary outcome measure

  • Prevalence of CPOP [ Time Frame: 6 (+ or - two weeks) months after surgery ]

Central Contacts and Locations

Central contacts

Locations

Montreal Heart Institute

Recruiting

Montréal, Quebec, Canada, H1T 1C8

Contacts

More Information

Sponsor

Montreal Heart Institute

Last update posted

Jan 26, 2018

Last verified

Jan, 2018

Keywords

  • chronic pain
  • cardiac surgery
  • opioids

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Montreal Heart Institute on 2018-01-26.